Product Information
TRIPLE ANTIBIOTIC OINTMENT is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $0.0888 per GM under NDC 45802014303. Its NADAC has been published 607 times since Feb 18, 2015.
Strength
400; 3.5; 5000 [USP'U]/g; mg/g; [USP'U]/g
Manufacturer
Padagis Israel Pharmaceuticals LtdNDC
45802014303
Classification
Generic
Dosage Form
OINTMENT
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M004On Market Since
5/20/2014
Pharmacological Classes
Price Statistics
The NADAC for TRIPLE ANTIBIOTIC OINTMENT has been published 607 times since Feb 18, 2015, and over the history we have for it it has risen 3.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0888 per GM |
|---|---|
| All-time high | $0.1072 (Nov 10, 2021) |
| All-time low | $0.0784 (Mar 20, 2024) |
| 52-week high | $0.0906 |
| 52-week low | $0.0800 |
| Median price | $0.0883 |
| Average price | $0.0889 |
| Largest weekly change | +30.9% (May 22, 2019) |
| Weeks tracked | 607 |
| Tracking since | Feb 18, 2015 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Padagis Israel Pharmaceuticals Ltd manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
bacitracin zinc, neomycin, polymyxin B market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Aminoglycoside Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TRIPLE ANTIBIOTIC OINTMENT?
The current National Average Drug Acquisition Cost (NADAC) for TRIPLE ANTIBIOTIC OINTMENT, manufactured by Padagis Israel Pharmaceuticals Ltd, is $0.0888 per GM (NDC 45802014303), effective Sep 30, 2026.
How has the price of TRIPLE ANTIBIOTIC OINTMENT changed over time?
Over the history we have for it, the NADAC for TRIPLE ANTIBIOTIC OINTMENT has risen 3.2%. It has been tracked across 607 weekly CMS publications since Feb 18, 2015.
What are the highest and lowest recorded NADAC prices for TRIPLE ANTIBIOTIC OINTMENT?
Since Feb 18, 2015, the NADAC for TRIPLE ANTIBIOTIC OINTMENT has ranged from a low of $0.0784 (Mar 20, 2024) to a high of $0.1072 (Nov 10, 2021), with a median of $0.0883 per GM.
Are there cheaper alternatives to TRIPLE ANTIBIOTIC OINTMENT?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TRIPLE ANTIBIOTIC OINTMENT in a comparable dosage form, but none are currently priced below it.
Who manufactures TRIPLE ANTIBIOTIC OINTMENT?
TRIPLE ANTIBIOTIC OINTMENT (NDC 45802014303) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.